Inventor
GUTIN ALEXANDER
US30 patents
⚠️ This page may combine multiple inventors who share the name “GUTIN ALEXANDER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MYRIAD GENETICS INC
25 patentsUS9279156B2Mar 8, 2016
Methods and materials for assessing allelic imbalance
MYRIAD GENETICS INC16 citations91
US9976188B2May 22, 2018
Cancer biomarkers
MYRIAD GENETICS INC5 citations83
US9574229B2Feb 21, 2017
Methods and materials for assessing allelic imbalance
MYRIAD GENETICS INC11 citations83
US12221656B2Feb 11, 2025
Methods and materials for assessing homologous recombination deficiency
MYRIAD GENETICS INC3 citations73
US11225685B2Jan 18, 2022
Methods and materials for assessing allelic imbalance
MYRIAD GENETICS INC1 citations72
US11174517B2Nov 16, 2021
Gene signatures for cancer prognosis
MYRIAD GENETICS INC4 citations72
US10876164B2Dec 29, 2020
Gene signatures for cancer prognosis
MYRIAD GENETICS INC5 citations72
US10626449B2Apr 21, 2020
Methods and materials for assessing allelic imbalance
MYRIAD GENETICS INC2 citations72
US10612098B2Apr 7, 2020
Methods and materials for assessing loss of heterozygosity
MYRIAD GENETICS INC2 citations72
US10519513B2Dec 31, 2019
Cancer Biomarkers
MYRIAD GENETICS INC1 citations72
US9388472B2Jul 12, 2016
Methods and materials for assessing loss of heterozygosity
MYRIAD GENETICS INC3 citations72
US11021752B2Jun 1, 2021
Genes and gene signatures for diagnosis and treatment of melanoma
MYRIAD GENETICS INC1 citations69
US11505832B2Nov 22, 2022
Method of using biomarkers and clinical variables for predicting chemotherapy benefit
MYRIAD GENETICS INC2 citations68
US10954568B2Mar 23, 2021
Gene signatures for cancer prognosis
MYRIAD GENETICS INC3 citations68
US12595513B2Apr 7, 2026
Methods and materials for assessing loss of heterozygosity
MYRIAD GENETICS INC0 citations61
US12421555B2Sep 23, 2025
Methods and materials for assessing homologous recombination deficiency
MYRIAD GENETICS INC0 citations61
US11174519B2Nov 16, 2021
Method of treating cancer
MYRIAD GENETICS INC0 citations61
US10400287B2Sep 3, 2019
Methods and materials for assessing homologous recombination deficiency
MYRIAD GENETICS INC1 citations61
US10612099B2Apr 7, 2020
Genes and gene signatures for diagnosis and treatment of melanoma
MYRIAD GENETICS INC1 citations59
US12180551B2Dec 31, 2024
Method of using biomarkers and clinical variables for predicting chemotherapy benefit
MYRIAD GENETICS INC0 citations57
US10851425B2Dec 1, 2020
Method for treating cancer
MYRIAD GENETICS INC0 citations51
US10501807B2Dec 10, 2019
Cancer biomarkers
MYRIAD GENETICS INC0 citations51
US7794933B1Sep 14, 2010
Depression-related gene
MYRIAD GENETICS INC0 citations46
US7662566B2Feb 16, 2010
Gene copy number profiling
MYRIAD GENETICS INC1 citations43
US12577622B2Mar 17, 2026
Detecting cancer risk
MYRIAD GENETICS INC0 citations41
MYRIAD MYPATH LLC
3 patentsUS11834719B2Dec 5, 2023
Genes and gene signatures for diagnosis and treatement of melanoma
MYRIAD MYPATH LLC3 citations68
US11584967B2Feb 21, 2023
Genes and gene signatures for diagnosis and treatment of melanoma
MYRIAD MYPATH LLC3 citations68
US12371750B2Jul 29, 2025
Genes and gene signatures for diagnosis and treatment of melanoma
MYRIAD MYPATH LLC0 citations57